Valuation: Synovics Pharmaceuticals, Inc.

Market Cap 1.64M 1.47M 1.37M 1.24M 2.34M 159M 2.36M 16.43M 6.42M 80.71M 6.16M 6.03M 259M P/E 2007
-0.73x
P/E 2008 -2.06x
Enterprise Value 8.13M 7.26M 6.78M 6.16M 11.59M 786M 11.68M 81.43M 31.81M 400M 30.52M 29.86M 1.29B EV / Sales 2007
1.81x
EV / Sales 2008 0.6x
Free-Float
95.75%
Yield 2007 *
-
Yield 2008 -
1 day+9,900.00%
6 months+9,900.00%
Current year 0
Extreme 1.0E-6
0
1 year 0
Extreme 1.0E-6
0
3 years 0
Extreme 1.0E-6
0
5 years 0
Extreme 1.0E-6
0
10 years 0
Extreme 1.0E-6
0
Change 5-day change 1-year change 3-year change Capi.($)
+9,900.00%-.--%-.--%-.--% 3.65K
+2.70%+2.73%+40.91%+110.31% 1,060B
+1.44%-2.38%+36.83%+63.95% 623B
+1.75%+3.73%+16.55%+83.05% 480B
+0.60%-1.73%+62.98%+37.46% 352B
-0.78%+3.12%+24.78%+45.10% 345B
-0.92%+0.05%+14.13%+35.80% 274B
-0.94%-0.81%-4.69%+12.20% 249B
+2.60%-2.00%+39.77%+54.44% 223B
+1.82%-1.48%+25.75%+96.48% 182B
Average +990.77%-0.44%+25.70%+53.88% 378.8B
Weighted average by Cap. +0.44%+0.04%+32.00%+70.72%

Financials

2007 2008
Net sales 23.47M 20.97M 19.56M 17.77M 33.46M 2.27B 33.71M 235M 91.84M 1.15B 88.1M 86.19M 3.71B 25.96M 23.19M 21.64M 19.66M 37.02M 2.51B 37.3M 260M 102M 1.28B 97.46M 95.35M 4.11B
Net income -20.86M -18.64M -17.39M -15.79M -29.74M -2.02B -29.97M -209M -81.63M -1.03B -78.3M -76.61M -3.3B -4.01M -3.58M -3.34M -3.03M -5.71M -388M -5.76M -40.13M -15.68M -197M -15.04M -14.71M -634M
Net Debt 18.79M 16.79M 15.66M 14.23M 26.8M 1.82B 27M 188M 73.54M 924M 70.54M 69.02M 2.97B 6.49M 5.8M 5.41M 4.91M 9.25M 628M 9.32M 65M 25.39M 319M 24.36M 23.83M 1.03B
Logo Synovics Pharmaceuticals, Inc.
Synovics Pharmaceuticals, Inc. (Synovics) is a specialty pharmaceutical company engaged in the development, manufacturing and commercialization of generic over the counter (OTC) pharmaceutical products and generic prescription drug products. The Company is a manufacturer, packager and distributor of private label, or store brand, OTC products to chain drug stores, wholesalers and distributors throughout the United States. The Company’s OTC product categories include analgesics, cough and cold, antihistamines, asthma relief and laxatives. The Company has two primary subsidiaries, Kirk Pharmaceuticals, LLC (Kirk), and ANDAPharm, LLC (ANDAPharm). Kirk manufactures and distributes OTC products developed by or licensed to the Company. ANDAPharm serves as the product research and RX manufacturing arm of the Company with a focus on the development of active compounds for drugs.
Employees
155
  1. Stock Market
  2. Stocks
  3. SYVC Stock